These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24465475)

  • 1. The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.
    Marshall AS; Barker CI; Pulickal AS; Kibwana E; Gautam SC; Clutterbuck EA; Thorson SM; Shrestha S; Adhikari N; Pollard AJ; Kelly DF
    PLoS One; 2014; 9(1):e85055. PubMed ID: 24465475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
    Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
    Kelly DF; Moxon ER; Yu LM; Pollard AJ
    Clin Vaccine Immunol; 2009 Feb; 16(2):246-52. PubMed ID: 18784340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
    Zarei AE; Linjawi MH; Redwan EM
    Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?
    Rodriguez RS; Mascarenas C; Conde-Glez CJ; Inostroza J; Villanueva S; Velázquez ME; Sánchez-Alemán MA; Echániz G
    Clin Vaccine Immunol; 2010 Oct; 17(10):1639-41. PubMed ID: 20719986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine.
    Mawas F; Peyre M; Beignon AS; Frost L; Del Giudice G; Rappuoli R; Muller S; Sesardic D; Partidos CD
    J Infect Dis; 2004 Sep; 190(6):1177-82. PubMed ID: 15319869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b reemergence after combination immunization.
    Johnson NG; Ruggeberg JU; Balfour GF; Lee YC; Liddy H; Irving D; Sheldon J; Slack MP; Pollard AJ; Heath PT
    Emerg Infect Dis; 2006 Jun; 12(6):937-41. PubMed ID: 16707049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Haemophilus influenzae Seroprevalence in Serum Samples Collected from 0- to 5-Year-Old Japanese Children in 1980, 1995, 2010, and 2012.
    Arai S; Satoh H; Okuno H; Morino S; Oishi K; Tanaka-Taya K
    Jpn J Infect Dis; 2020 Jan; 73(1):51-54. PubMed ID: 31474695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.
    Metz JA; Hanieh S; Pradhan R; Joshi A; Shakya D; Shrestha L; Shrestha A; Upadhyay B; Kelly SC; John TM; Maharjan BD; Yu LM; Omar O; Borrow R; Findlow J; Kelly DF; Thorson SM; Adhikari N; Murdoch DR; Pollard AJ
    Pediatr Infect Dis J; 2012 Apr; 31(4):e66-72. PubMed ID: 22418662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.
    Shrestha S; Stockdale LK; Gautam MC; Gurung M; Feng S; Maskey P; Kerridge S; Kelly S; Voysey M; Pokhrel B; Rajbhandari P; Thorson S; Khadka B; Shah G; Scherer KS; Kelly D; Murdoch DR; Shrestha S; Pollard AJ
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S267-S274. PubMed ID: 34469554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.